COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021

Abstract

What is already known about this topic? Although more common among adults, severe COVID-19 illness and hospitalization occur among adolescents. What is added by this report? As of July 31,2021, coverage with >1 dose of COVID-19 vaccine among adolescents aged 12-17 years was 42%, and 32% had completed the series. Series completion rates varied widely by state, ranging from 11% to 60%, and was 25% for adolescents aged 12-13 years, 30% for those aged 14-15 years, and 40% for those aged 16-17 years. What are the implications for public health practice? Improving adolescent COVID-19 vaccination coverage is crucial to reduce COVID-19-associated morbidity and mortality among adolescents and can help facilitate safer reopening of schools for in-person learning.